Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may amplify the drug's ability to regulate blood levels, potentially offering improved outcomes for individuals with insulin resistance. Further investigation is underway to fully understand